Literature DB >> 33483137

Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.

Jianhua Wu, Mamas A Mamas, Mark A de Belder, John E Deanfield, Chris P Gale.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33483137      PMCID: PMC8888028          DOI: 10.1016/j.jacc.2020.12.039

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, there was a decline in admissions with cardiovascular disease, corresponding to social containment mandates (1, 2, 3). It is not clear whether widespread media coverage around this phenomenon during the first wave would potentially lessen the effect of any subsequent social containment mandates on cardiovascular admissions. Using data from the NHFA (National Heart Failure Audit) and MINAP (Myocardial Ischaemia National Audit Project), we examined whether the public response to the second national lockdown in the United Kingdom replicated that of the first. We studied the daily incidence of admissions with heart failure (HF) and myocardial infarction (MI) among adults in the National Institute for Cardiovascular Outcomes Research databank between November 1, 2018, and November 17, 2020. To avoid data reporting lag bias, we only included rapid reporting hospitals (22 and 42 hospitals for NHFA and MINAP, respectively) for the analysis. We compared the daily incidence of hospital admissions for the pre–COVID-19 period (November 1, 2018, to March 22, 2020) with that of the nadir and peak following the first UK lockdown and the rates in the second UK lockdown to date of latest available data (November 17, 2020). Incidence rate ratios, estimated from an interrupted times series using a generalized linear model for a Poisson distribution fitted and adjusted for seasonality with a harmonic term, were used to compare the relative change in event rates between the periods. All datasets used in our study collect information routinely used for audit research purposes without requiring informed patient consent under section 251 of the National Health Service Act 2006, and therefore, institutional board review was not required for this study. Access to datasets required for this study has been fast-tracked by adopting a novel collaboration as part of the national drive for research related to COVID-19. For the rapid reporting hospitals, there were 62,683 admissions with HF and MI between November 1, 2018, and November 17, 2020. From March 23, 2020 (first UK lockdown), daily HF and MI hospitalizations decreased by 54% (incident rate ratio [IRR]: 0.46; 95% confidence interval [CI]: 0.41 to 0.51) and by 32% (IRR: 0.68; 95% CI: 0.65 to 0.73) to a nadir on April 2, 2020, and April 4, 2020, respectively (Figure 1A ). For admissions with HF and MI, peak recovery occurred on June 16, 2020, and June 29, 2020, respectively, but remained at 95% (IRR: 0.95; 95% CI: 0.91 to 0.99) and 93% (IRR: 0.93; 95% CI: 0.90 to 0.95) of pre–COVID-19 rates. From the beginning of October 2020, there was a second decline in admissions by 41% for HF (IRR: 0.59; 95% CI: 0.54 to 0.64) and by 34% for MI (IRR: 0.66; 95% CI: 0.63 to 0.69) up to November 17, 2020, compared with the pre–COVID-19 period. As a comparison, there was little variation in admissions with HF and MI in the baseline year between 2018 and 2019 (Figure 1B).
Figure 1

Times Series of Daily Admissions With HF and MI

The daily admission data were presented for heart failure (HF) and myocardial infarction (MI) from November 1, 2019, to November 17, 2020 (30,380 admissions) (A) and from November 1, 2018, to November 17, 2019 (33,831 admissions) (B). Daily hospitalizations were plotted in a scatterplot and fitted with a smooth curve using local weighted scatterplot smoothing technique for HF and acute MI, respectively. The peak and nadir of daily hospitalizations were derived from the fitted curve. (Updates of the figure will be available at the University of Leeds’s Cardiovascular Research Into the COVID-19 Virus website.) COVID-19 = coronavirus disease 2019; WHO = World Health Organization.

Times Series of Daily Admissions With HF and MI The daily admission data were presented for heart failure (HF) and myocardial infarction (MI) from November 1, 2019, to November 17, 2020 (30,380 admissions) (A) and from November 1, 2018, to November 17, 2019 (33,831 admissions) (B). Daily hospitalizations were plotted in a scatterplot and fitted with a smooth curve using local weighted scatterplot smoothing technique for HF and acute MI, respectively. The peak and nadir of daily hospitalizations were derived from the fitted curve. (Updates of the figure will be available at the University of Leeds’s Cardiovascular Research Into the COVID-19 Virus website.) COVID-19 = coronavirus disease 2019; WHO = World Health Organization. Despite an initial recovery in admissions with HF and MI, the latter part of 2020 has witnessed a second decline in people hospitalized with these conditions, which pre-dated the onset of the second national lockdown in the United Kingdom. The second dip appears of similar magnitude to that of the first and signals that the public are fearful of attending hospitals despite having medical emergencies, and that this varies over time—possibly relating to numbers of cases and social mandates. Given that the period cohort for this analysis cannot determine a nadir in admissions, rates of admissions may decline further. This is important because earlier work from the United Kingdom described how delays to seeking help were temporally related to an inflation in deaths from a range of acute cardiovascular diseases (4,5). Clear public messaging is necessary to prevent further unintended consequences of social distancing mandates to reduce the spread of severe acute respiratory syndrome coronavirus 2.
  5 in total

1.  The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.

Authors:  Matthew D Solomon; Edward J McNulty; Jamal S Rana; Thomas K Leong; Catherine Lee; Sue-Hee Sung; Andrew P Ambrosy; Stephen Sidney; Alan S Go
Journal:  N Engl J Med       Date:  2020-05-19       Impact factor: 91.245

2.  Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic.

Authors:  Jianhua Wu; Mamas Mamas; Muhammad Rashid; Clive Weston; Julian Hains; Tom Luescher; Mark A de Belder; John E Deanfield; Chris P Gale
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-05-03

3.  Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.

Authors:  Amitava Banerjee; Laura Pasea; Steve Harris; Arturo Gonzalez-Izquierdo; Ana Torralbo; Laura Shallcross; Mahdad Noursadeghi; Deenan Pillay; Neil Sebire; Chris Holmes; Christina Pagel; Wai Keong Wong; Claudia Langenberg; Bryan Williams; Spiros Denaxas; Harry Hemingway
Journal:  Lancet       Date:  2020-05-12       Impact factor: 79.321

4.  COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.

Authors:  Marion M Mafham; Enti Spata; Raphael Goldacre; Dominic Gair; Paula Curnow; Mark Bray; Sam Hollings; Chris Roebuck; Chris P Gale; Mamas A Mamas; John E Deanfield; Mark A de Belder; Thomas F Luescher; Tom Denwood; Martin J Landray; Jonathan R Emberson; Rory Collins; Eva J A Morris; Barbara Casadei; Colin Baigent
Journal:  Lancet       Date:  2020-07-14       Impact factor: 79.321

5.  Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.

Authors:  Jianhua Wu; Mamas A Mamas; Mohamed O Mohamed; Chun Shing Kwok; Chris Roebuck; Ben Humberstone; Tom Denwood; Thomas Luescher; Mark A de Belder; John E Deanfield; Chris P Gale
Journal:  Heart       Date:  2020-09-28       Impact factor: 5.994

  5 in total
  19 in total

1.  Rates of Acute Myocardial Infarction During the COVID-19 Pandemic.

Authors:  Matthew T Mefford; Jaejin An; Nigel Gupta; Teresa N Harrison; Steven J Jacobsen; Ming-Sum Lee; Paul Muntner; Chileshe Nkonde-Price; Lei Qian; Kristi Reynolds
Journal:  Perm J       Date:  2021-12-13

2.  Heart failure care pathways: the power of collaboration and marginal gains.

Authors:  Carys Barton; Simon Gordon; Afsana Safa; Carla M Plymen
Journal:  Br J Cardiol       Date:  2022-01-26

3.  Admission Rates During a Second COVID-19 Lockdown.

Authors:  Daniel Mølager Christensen; Jawad Haider Butt; Emil Fosbøl; Lars Køber; Christian Torp-Pedersen; Gunnar Gislason; Matthew Phelps
Journal:  Am Heart J       Date:  2021-07-15       Impact factor: 4.749

4.  Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial.

Authors:  Thomas A Kite; Amerjeet S Banning; Andrew Ladwiniec; Chris P Gale; John P Greenwood; Miles Dalby; Rachel Hobson; Shaun Barber; Emma Parker; Colin Berry; Marcus D Flather; Nick Curzen; Adrian P Banning; Gerry P McCann; Anthony H Gershlick
Journal:  BMJ Open       Date:  2022-05-03       Impact factor: 3.006

5.  How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic.

Authors:  Artur Fedorowski; David Erlinge
Journal:  Int J Cardiol       Date:  2021-04-12       Impact factor: 4.164

6.  Reassuring cardiac and non-cardiac outcomes for heart failure patients managed in a disease management programme during the COVID-19 pandemic.

Authors:  Joseph McCambridge; Katherine McDonald; Líbhan Collins; Barry Dyer; Carmel Halley; Matthew Barrett; Mark Ledwidge; Kenneth McDonald
Journal:  Int J Cardiol Heart Vasc       Date:  2021-12-28

Review 7.  Acute Myocardial Infarction During the COVID-19 Pandemic: An Update on Clinical Characteristics and Outcomes.

Authors:  Olga Toscano; Nicola Cosentino; Jeness Campodonico; Antonio L Bartorelli; Giancarlo Marenzi
Journal:  Front Cardiovasc Med       Date:  2021-12-23

Review 8.  Digital Technology Application for Improved Responses to Health Care Challenges: Lessons Learned From COVID-19.

Authors:  Darshan H Brahmbhatt; Heather J Ross; Yasbanoo Moayedi
Journal:  Can J Cardiol       Date:  2021-12-01       Impact factor: 5.223

9.  Excess deaths from COVID-19 and other causes by region, neighbourhood deprivation level and place of death during the first 30 weeks of the pandemic in England and Wales: A retrospective registry study.

Authors:  Evangelos Kontopantelis; Mamas A Mamas; Roger T Webb; Ana Castro; Martin K Rutter; Chris P Gale; Darren M Ashcroft; Matthias Pierce; Kathryn M Abel; Gareth Price; Corinne Faivre-Finn; Harriette G C Van Spall; Michelle M Graham; Marcello Morciano; Glen P Martin; Tim Doran
Journal:  Lancet Reg Health Eur       Date:  2021-06-08

10.  Persistent decline of hospitalizations for acute stroke and acute coronary syndrome during the second wave of the COVID-19 pandemic in Greece: collateral damage unaffected.

Authors:  Christos Katsouras; Georgios Tsivgoulis; Michail Papafaklis; Theodore Karapanayiotides; Dimitrios Alexopoulos; Evangelos Ntais; Georgia Papagiannopoulou; Ioanna Koutroulou; Antonios Ziakas; Georgios Sianos; Antonios Kouparanis; Paraskevi Trivilou; Christos Ballas; Ioanna Samara; Maria Kosmidou; Lina Palaiodimou; Nikolaos Grigoriadis; Lampros K Michalis; Sotirios Giannopoulos
Journal:  Ther Adv Neurol Disord       Date:  2021-07-07       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.